Relay Therapeutics, Inc.
RLAY- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001812364
In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 14 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Relay Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 132
- +7 vs. Q2 2021
- Shares held
- 91.8M
- +2.63M (+3.0%) vs. Q2 2021
- Total value
- $2.89B
- −$366.8M (−11.2%) vs. Q2 2021
- New holders
- 21
- 55 more added
- Sold out
- 14
- 29 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RLAY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 259 | $4.58B |
| Q1 2026 | 244 | $1.83B |
| Q4 2025 | 227 | $1.47B |
| Q3 2025 | 199 | $867.4M |
| Q2 2025 | 208 | $591.8M |
| Q1 2025 | 208 | $438.1M |
| Q4 2024 | 200 | $675.8M |
| Q3 2024 | 195 | $1.16B |
| Q2 2024 | 179 | $826.8M |
| Q1 2024 | 189 | $1.10B |
| Q4 2023 | 177 | $1.40B |
| Q3 2023 | 172 | $1.10B |
| Q2 2023 | 161 | $1.64B |
| Q1 2023 | 157 | $2.16B |
| Q4 2022 | 165 | $1.91B |
| Q3 2022 | 162 | $2.76B |
| Q2 2022 | 148 | $2.02B |
| Q1 2022 | 140 | $3.38B |
| Q4 2021 | 131 | $3.41B |
| Q3 2021 | 132 | $2.89B |
| Q2 2021 | 125 | $3.26B |
| Q1 2021 | 137 | $2.96B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Relay Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Woodline Partners LP | 255,601 | $8.06M | 0.13% | −32,956−11.4% | Reduced |
| HarbourVest Partners LLC | 296,402 | $9.35M | 0.88% | 00.0% | Unchanged |
| Artal Group S.A. | 400,000 | $12.6M | 0.31% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 428,322 | $13.5M | 0.00% | +205,352+92.1% | Added |
| ArrowMark Colorado Holdings LLC | 442,733 | $14.0M | 0.11% | +70,538+19.0% | Added |
| Morgan Stanley | 446,791 | $14.1M | 0.00% | −122,854−21.6% | Reduced |
| Rock Springs Capital Management LP | 469,560 | $14.8M | 0.31% | +19,302+4.3% | Added |
| Norges Bank | 497,765 | $15.7M | 0.00% | +267,135+115.8% | Added |
| Harvard Management Co Inc | 541,124 | $17.1M | 1.00% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 562,938 | $17.7M | 0.12% | 00.0% | Unchanged |
| Northern Trust Corp | 575,928 | $18.2M | 0.00% | +53,822+10.3% | Added |
| Bessemer Group Inc | 584,463 | $18.4M | 0.04% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 600,000 | $18.9M | 0.04% | 00.0% | Unchanged |
| Gilder Gagnon Howe & Co LLC | 761,743 | $24.0M | 0.12% | −73,795−8.8% | Reduced |
| Geode Capital Management, LLC | 1,065,260 | $33.6M | 0.00% | +357,365+50.5% | Added |
| Boxer Capital, LLC | 1,294,132 | $40.8M | 1.43% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 1,354,263 | $42.7M | 0.02% | +109,498+8.8% | Added |
| EcoR1 Capital, LLC | 1,385,276 | $43.7M | 1.54% | −3,102,500−69.1% | Reduced |
| Wellington Management Group LLP | 1,407,841 | $44.4M | 0.01% | +139,654+11.0% | Added |
| JPMorgan Chase & Co | 1,426,982 | $45.0M | 0.01% | +3,655+0.3% | Added |
| Price T Rowe Associates Inc | 1,617,953 | $51.0M | 0.00% | +444,471+37.9% | Added |
| Alphabet Inc. | 1,641,497 | $51.8M | 1.23% | −185,379−10.1% | Reduced |
| Perceptive Advisors LLC | 1,943,097 | $61.3M | 0.89% | −75,000−3.7% | Reduced |
| BVF Inc | 2,049,113 | $64.6M | 2.52% | −889,089−30.3% | Reduced |
| State Street Corp | 2,681,676 | $84.6M | 0.00% | +463,516+20.9% | Added |
| Driehaus Capital Management LLC | 3,050,702 | $96.2M | 1.14% | +196,662+6.9% | Added |
| Casdin Capital, LLC | 3,668,574 | $115.7M | 2.89% | +293,516+8.7% | Added |
| Bellevue Group AG | 3,755,962 | $118.4M | 1.20% | +1,115,000+42.2% | Added |
| Vanguard Group Inc | 4,884,037 | $154.0M | 0.00% | +590,595+13.8% | Added |
| BlackRock Inc. | 5,352,612 | $168.8M | 0.00% | +812,282+17.9% | Added |
| FMR LLC | 13,686,804 | $431.5M | 0.03% | +3,324,804+32.1% | Added |
| SB Investment Advisers (UK) Ltd | 27,904,963 | $879.8M | 2.73% | 00.0% | Unchanged |
| Foresite Capital Management IV, LLC | 0 | $0 | 0.00% | −556,380−100.0% | Sold out |
| Foresite Capital Management V, LLC | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −125,651−100.0% | Sold out |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −119,775−100.0% | Sold out |
| TCW Group Inc | 0 | $0 | 0.00% | −80,943−100.0% | Sold out |
| Hershey Trust Co | 0 | $0 | 0.00% | −59,360−100.0% | Sold out |
| Nomura Asset Management Co Ltd | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −8,448−100.0% | Sold out |
| Quantitative Systematic Strategies LLC | 0 | $0 | 0.00% | −8,246−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −6,236−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −1,010−100.0% | Sold out |
| Savior LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −7−100.0% | Sold out |